B7 costimulatory requirements of T cells at an inflammatory site

Journal of Immunology

Volumn 160, Issue 10, 1998, Pages 5045-5052

  Chen, Haixiao ^a   Hendricks, Robert L ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD86 ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ARTICLE; CELL MIGRATION; CONJUNCTIVA; CONTROLLED STUDY; CORNEA EPITHELIUM; FEMALE; HERPES SIMPLEX KERATITIS; HERPES SIMPLEX VIRUS 1; IMMUNOSTIMULATION; INFLAMMATION; LANGERHANS CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIGENS, CD80; CELL MOVEMENT; FEMALE; INFLAMMATION; KERATITIS, HERPETIC; LANGERHANS CELLS; LYMPHOCYTE ACTIVATION; MICE; T-LYMPHOCYTES; TH1 CELLS;

EID: 0032525050     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Chen, W., Q. Tang, and R. L. Hendricks. 1996. Ex vivo model of leukocyte migration into herpes simplex virus-infected mouse corneas. J. Leukocyte Biol. 60:167.
2. Hendricks, R. L., T. M. Tumpey, and A. Finnegan. 1992. IFN-γ and IL-2 are protective in the skin but pathologic in the corneas of HSV-1 -infected mice. J. Immunol. 149:3023.
3. Newell, C. K., S. Martin, D. Sendele, C. M. Mercadal, and B. T. Rouse. 1989. Herpes simplex virus-induced stromal keratitis: role of T-lymphocyte subsets in immunopathology. J. Virol. 63:769.
4. Niemialtowski, M., and B. Rouse. 1992. Phenotypic and functional studies on ocular T cells during herpetic infections of the eye. J. Immunol. 148:1864.
5. Tang, Q., and R. L. Hendricks. 1996. IFN-gamma regulates PECAM-1 expression and neutrophil infiltration into herpes simplex virus-infected mouse corneas. J. Exp. Med. 184:1435.
6. Tang, Q., W. Chen, and R. L. Hendricks. 1997. Proinflammatory functions of IL-2 in herpes simplex virus corneal infection. J. Immunol. 158:1275.
7. Shaw, G., and R. Kamen. 1986. A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell 46:659.
8. Rodrigues, M., G. Rowden, J. Hackett, and I. Bakos. 1997. Langerhans cells in the normal conjunctiva and peripheral cornea of selected species. Invest. Ophthalmol. Visual Sci. 21:759.
9. Hendricks, R. L., M. Janowicz, and T. M. Tumpey. 1992. Critical role of corneal Langerhans cells in the CD4- but not CD8-mediated immunopathology in herpes simplex virus-1-infected mouse corneas. J. Immunol. 148:2522.
10. Repose, J. S. 1989. The relationship of corneal Langerhans cells to herpes simplex antigens during dendritic keratitis. Curr. Eye Res. 8:851.
11. Miller, J. K., K. A. Laycock, M. M. Nash, and J. S. Repose. 1993. Corneal Langerhans cell dynamics after herpes simplex virus reactivation. Invest. Ophthalmol. Visual Sci. 34:2282.
12. Jager, M. J., D. Bradley, S. S. Atherton, and J. W. Streilein. 1992. Presence of Langerhans cells in the central cornea linked to the development of ocular herpes in mice. Exp. Eye Res. 54:835.
13. McLeish, W., P. Rubsamen, S. S. Atherton and J. W. Streilein. 1989. Immunobiology of Langerhans cells on the ocular surface. II. Role of central corneal Langerhans cells in stromal keratitis following experimental HSV-1 infection in mice. Reg. Immunol. 2:236.
14. Steinman, R. M. 1991. The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol. 9:271.
15. van Wilsem, E. J., J. Breve, M. Kleijmeer, and G. Kraal. 1994. Antigen-bearing Langerhans cells in skin draining lymph nodes: phenotype and kinetics of migration. Immunol. Rev. 153:85.
16. Furue, M., C. H. Chang, and K. Tamaki. 1996. Interleukin-1 but not tumour necrosis factor α synergistically upregulates the granulocyte-macrophage colony-stimulating factor-induced B7-1 expression of murine Langerhans cells. Br. J. Dermatol. 135:194.
17. Larsen, C. P., S. C. Ritchie, R. Hendrix, P. S. Linsley, K. S. Hathcock, R. J. Hodes, R. P. Lowry, and T. C. Pearson. 1997. Regulation of immunostimulatory function and costimulatory molecule (B7-1 and B7-2) expression on murine dendritic cells. J. Immunol. 152:5208.
18. Caux, C., C. Massacrier, B. Vanbervliet, B. Dubois, C. Van Kooten, I. Durand, and J. Banchereau. 1994. Activation of human dendritic cells through CD40 cross-linking. J. Exp. Med. 180:1263.
19. Boussiotis, V. A., G. J. Freeman, J. G. Gribben, and L. M. Nadler. 1996. The role of B7-1/B7-2:CD28/CTLA-4 pathway in the prevention of anergy, induction of productive immunity and down-regulation of the immune response. Immunol. Rev. 153:5.
20. Sperling, A. I., and J. A. Bluestone. 1996. The complexities of T-cell co-stimulation: CD28 and beyond. Immunol. Rev. 153:155.
21. Miller, S. D., C. L. Vanderlugt, D. J. Lenschow, J. G. Pope, N. J. Karandikar, M. C. Dal Cannto, and J. A. Bluestone. 1996. Blockade of CD28/B7-1 interaction prevents epitope spreading and clinical relapses of murine EAE. Immunity 3:739.
22. Khoury, S. J., L. Gallon, R. R. Verburg, A. Chandraker, R. Peach, P. S. Linsley, L. A. Turka, W. W. Hancock, and M. H. Sayegh. 1996. Ex vivo treatment of antigen-presenting cells with CTLA4Ig and encephalitogenic peptide prevents experimental autoimmune encephalomyelitis in the Lewis rat. J. Immunol. 157:3700.
23. Kuchroo, V. K., M. P. Das, J. A. Brown, A. M. Ranger, S. S. Zamvil, R. A. Sobel, H. L. Weiner, N. Nabavi, and L. H. Glimcher. 1995. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell 80:707.
24. Lenschow, D. J., K. C. Herold, L. Rhee, B. Patel, A. Koons, H.-Y. Qin, E. Fuchs, B. Singh, C. B. Thompson, and J. A. Bluestone. 1996. CD28/B7 regulation of Th1 and Th2 subsets in the development of autoimmune diabetes. Immunity 5:285.
25. Lenschow, D. J., S. C. Ho, H. Sattar, L. Rhee, G. Gray, N. Nabavi, K. C. Herold, and J. A. Bluestone. 1995. Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse. J. Exp. Med. 181:1145.
26. Chakrabarti, D., B. Hultgren, and T. A. Stewart. 1996. IFN-α induces autoimmune T cells through the induction of intracellular adhesion molecule-1 and B7-2. J. Immunol. 157:522.
27. Reiser, H., and E. E. Schneeberger. 1997. Expression and function of B7-1 and B7-2 in hapten-induced contact sensitivity. Eur. J. Immunol. 26:880.
28. Windhagen, A., J. Newcombe, F. Dangond, C. Strand, M. N. Woodroofe, M. L. Cuzner, and D. A. Hafler. 1995. Expression of costimulatory molecules B7-1 (CD80), B7-2 (CD86), and interleukin 12 cytokine in multiple sclerosis lesions. J. Exp. Med. 182:1985.
29. Simon, J. C., A. Dietrich, and V. Mielke. 1994. Expression of the B7/BB1 activation antigen and its ligand CD28 in T cell-mediated skin diseases. J. Invest. Dermatol. 103:539.
30. Imagawa, A., T. Hanafusa, N. Itoh, J. Miyagawa, and D. M. Harlan. 1996. Islet infiltrating T-lymphocytes in insulin-dependent diabetes patients express CD80 (B7-1) and CD86 (B7-2). J. Autoimmun. 9:391.
31. Hendricks, R. L., and J. Sugar. 1984. Lysis of herpes simplex virus-infected targets. II. Nature of the effector cells. Cell. Immunol. 83:262.
32. Hendricks, R. L., R. J. Epstein, M. A. G. Viana, and D. A. Hoffmann, 1990. A reproducible method for performing injections into the mouse corneal stroma. Invest. Ophthalmol. Visual Sci 32:366.
33. Hendricks, R. L., and T. M. Tumpey. 1990. Contribution of virus and immune factors to herpes simplex virus type 1 induced corneal pathology. Invest. Ophthalmol. Visual Sci. 31:1929.
34. Winzler, C., P. Rovere, M. Rescigno, F. Granucci, G. Penna, L. Adorini, V. S. Zimmerman, J. Davoust, and P. Ricciardi-Castagnoli. 1997. Maturation stages of mouse dendritic cells in growth factor-dependent long-term cultures. J. Exp. Med. 185:317.
35. Cumberbatch, M., and I. Kimber. 1992. Dermal tumour necrosis factor-α induces dendritic cell migration to draining lymph nodes, and possibly provides one stimulus for Langerhans' cell migration. Immunology 75:257.
36. Chang, C.-H., M. Furue, and K. Tamaki. 1995. B7-1 expression of Langerhans cells is up-regulated by proinflammatory cytokines, and is down-regulated by interferon-gamma or by interleukin-10. Eur. J. Immunol. 25:394.
37. Larsen, C. P., R. M. Steinman, M. D. Witmer-Pack, D. F. Hankins, P. J. Morris, and J. M. Austyn. 1990. Migration and maturation of Langerhans cells in skin transplants and explants. J. Exp. Med. 172:1483.
38. Staats, H. F., and R. N. Lausch. 1993. Cytokine expression in vivo during murine herpetic stromal keratitis. J. Immunol. 151:277.
39. Wang, B., S. Kondo, G. M. Shivji, H. Fujisawa, T. W. Mak, and D. N. Sauder. 1996. Tumour necrosis factor receptor II (p75) signalling is required for the migration of Langerhans' cells. Immunology 88:284.
40. Koch, P., C. Heufler, E. Kampgen, D. Schneeweiss, G. Bock, and G. Schuler. 1990. Tumor necrosis factor α maintains the viability of murine epidermal Langerhans cells in culture, but in contrast to granulocyte/macrophage colony-stimulating factor, without inducing their functional maturation. J. Exp. Med. 171:159.
41. Grewal, I. S., and R. A. Flavell. 1996. The role of CD40 ligand in costimulation and T-cell activation. Immunol. Rev. 153:85.
42. Cause, W. C., V. Mitro, C. S. Via, P. Linsley, J. Urban, Jr., and R. J. Greenwald. 1997. Do effector and memory T helper cells also need B7 ligand costimulatory signals? J. Immunol, 159:1055.
43. Lenschow, D. J., T. L. Walunas, and J. A. Bluestone. 1996. CD28/B7 system of T cell costimulation. Annu. Rev. Immunol. 14:233.